Royal Bank of Canada’s NanoViricides NNVC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-30,535
| Closed | -$43K | – | 7374 |
|
|
2025
Q2 | $43K | Hold |
30,535
| – | – | ﹤0.01% | 5988 |
|
|
2025
Q1 | $36K | Hold |
30,535
| – | – | ﹤0.01% | 5689 |
|
|
2024
Q4 | $44K | Hold |
30,535
| – | – | ﹤0.01% | 5756 |
|
|
2024
Q3 | $46K | Hold |
30,535
| – | – | ﹤0.01% | 5742 |
|
|
2024
Q2 | $53K | Hold |
30,535
| – | – | ﹤0.01% | 5626 |
|
|
2024
Q1 | $35K | Hold |
30,535
| – | – | ﹤0.01% | 5687 |
|
|
2023
Q4 | $31K | Hold |
30,535
| – | – | ﹤0.01% | 6175 |
|
|
2023
Q3 | $41K | Buy |
+30,535
| New | +$43.2K | ﹤0.01% | 5882 |
|
|
2022
Q4 | – | Sell |
-1
| Closed | – | – | 7551 |
|
|
2022
Q3 | $0 | Buy |
+1
| New | +$2 | ﹤0.01% | 7707 |
|
|
2021
Q1 | – | Sell |
-29
| Closed | – | – | 7604 |
|
|
2020
Q4 | $0 | Sell |
29
-6
| -17% | -$22 | ﹤0.01% | 7215 |
|
|
2020
Q3 | $0 | Hold |
35
| – | – | ﹤0.01% | 6826 |
|
|
2020
Q2 | $0 | Hold |
35
| – | – | ﹤0.01% | 6809 |
|
|
2020
Q1 | $0 | Hold |
35
| – | – | ﹤0.01% | 6914 |
|
|
2019
Q4 | $0 | Hold |
35
| – | – | ﹤0.01% | 7019 |
|
|
2019
Q3 | $0 | Hold |
35
| – | – | ﹤0.01% | 6967 |
|
|
2019
Q2 | $0 | Hold |
35
| – | – | ﹤0.01% | 7071 |
|
|
2019
Q1 | $0 | Hold |
35
| – | – | ﹤0.01% | 6995 |
|
|
2018
Q4 | $0 | Hold |
35
| – | – | ﹤0.01% | 6994 |
|
|
2018
Q3 | $0 | Hold |
35
| – | – | ﹤0.01% | 6871 |
|
|
2018
Q2 | $0 | Hold |
35
| – | – | ﹤0.01% | 6689 |
|
|
2018
Q1 | $1K | Hold |
35
| – | – | ﹤0.01% | 6213 |
|
|
2017
Q4 | $1K | Sell |
35
-113
| -76% | -$2.31K | ﹤0.01% | 6404 |
|
|
2017
Q3 | $3K | Buy |
148
+113
| +323% | +$3.04K | ﹤0.01% | 6516 |
|
|
2017
Q2 | $1K | Hold |
35
| – | – | ﹤0.01% | 6418 |
|
|
2017
Q1 | $1K | Hold |
35
| – | – | ﹤0.01% | 6519 |
|
|
2016
Q4 | $1K | Sell |
35
-1,250
| -97% | -$33.3K | ﹤0.01% | 6559 |
|
|
2016
Q3 | $43K | Buy |
1,285
+179
| +16% | +$5.93K | ﹤0.01% | 5232 |
|
|
2016
Q2 | $35K | Buy |
1,106
+1,071
| +3,060% | +$39.1K | ﹤0.01% | 5264 |
|
|
2016
Q1 | $2K | Sell |
35
-17
| -33% | -$660 | ﹤0.01% | 6131 |
|
|
2015
Q4 | $1K | Hold |
52
| – | – | ﹤0.01% | 6484 |
|
|
2015
Q3 | $1K | Hold |
52
| – | – | ﹤0.01% | 6498 |
|
|
2015
Q2 | $2K | Hold |
52
| – | – | ﹤0.01% | 6376 |
|
|
2015
Q1 | $3K | Sell |
52
-250
| -83% | -$13.3K | ﹤0.01% | 5856 |
|
|
2014
Q4 | $17K | Buy |
302
+250
| +481% | +$16.5K | ﹤0.01% | 5456 |
|
|
2014
Q3 | $3K | Sell |
52
-7
| -12% | -$550 | ﹤0.01% | 5749 |
|
|
2014
Q2 | $5K | Hold |
59
| – | – | ﹤0.01% | 5566 |
|
|
2014
Q1 | $3K | Buy |
59
+35
| +146% | +$2.99K | ﹤0.01% | 5671 |
|
|
2013
Q4 | $3K | Buy |
+24
| New | +$2.47K | ﹤0.01% | 5704 |
|
Other funds holding NNVC
BCM
MAWA
Royal Bank of Canada's NNVC Position: Q3 2025 in Review
Royal Bank of Canada sold out of NanoViricides (NNVC) in Q3 2025, closing a stake of 30,535 shares — an estimated $43K sold.
Royal Bank of Canada first reported a position in NNVC in Q4 2013 and held it in 38 quarters. The position peaked at $53K in Q2 2024. 35 funds tracked by Wall St. Rank hold NNVC as of Q3 2025.
- Royal Bank of Canada reported no remaining NanoViricides position as of Q3 2025 after selling out during the quarter.
- Royal Bank of Canada sold 30,535 NanoViricides shares in Q3 2025, an estimated $43K.
- Royal Bank of Canada first reported a position in NanoViricides in Q4 2013 and held it in 38 quarters.
- Royal Bank of Canada's NanoViricides position peaked at $53K in Q2 2024.
- 35 funds tracked by Wall St. Rank held NanoViricides as of Q3 2025.
Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.